Episode Details

Dr. Michael Drues: The Consumerization of MedTech

Ep. 37

For medical device companies, the consumerization of Medtech represents a new paradigm. In the past, medical devices were more targeted toward healthcare providers and payers – now there is a demand for direct-to-consumer products.  People are demanding to have more control over their healthcare and they want the ability to proactively manage it.  The connected health and wellness devices market is expected to reach $612 billion by 2024, according to a report by Grand View Research Inc. and the wearable medical device market alone is projected to reach $14.41 billion by 2022, according to Markets&Markets Inc.  As Medtech explores opportunities within this business model, this consumerization will forever change how healthcare is delivered and medical device evolve.  

In this episode of DeviceAlliance’s Medtech Radio, we speak with the FDA Consultant and President of Vascular Sciences, Dr. Michael Drues.  Join us as we discuss the consumerization of Medtech, defining what is a medical device vs. wellness device with respect to regulation,  the "essence" of these distinctions, interpretation of words, and one's ability to defend them in regulation, "Class 0" devices, and wellness devices impact on the evolution of medical devices.

37

Follow the great work Michael and team are doing at Vascular Sciences.

Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!

OTHER MEDTECH RADIO EPISODES

  • All
  • Entrepreneurship/Startups
  • Leadership Spotlight
  • Marketing & Product Development
  • Professional Development
  • Women in MedTech
  • Young Professionals

Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43

You’ve got a great idea for a medical device!  Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success.   With the explosion of Medtech opportunities for startups, what are the current